CTPA: Indications and Contraindications
CTPA is indicated for patients with intermediate or high pretest probability of PE, or for those with low/intermediate probability who have a positive D-dimer test; it should NOT be performed in patients with low pretest probability and negative D-dimer, as this combination safely excludes PE without imaging. 1, 2
Algorithmic Approach to CTPA Utilization
Step 1: Assess Clinical Pretest Probability
Use validated clinical prediction rules (Wells criteria or Geneva score) to stratify patients into low, intermediate, or high probability categories 1, 3.
Step 2: Apply Risk-Stratified Diagnostic Strategy
Low Pretest Probability:
- Check D-dimer first
- If D-dimer negative (using age-adjusted cutoff: age × 10 ng/mL for patients >50 years): Stop—no imaging needed 1
- If D-dimer positive: Proceed to CTPA 3
Intermediate Pretest Probability:
- Check D-dimer first
- If D-dimer negative: Stop—no imaging needed 3, 1
- If D-dimer positive: Proceed to CTPA 3
High Pretest Probability:
- Skip D-dimer testing entirely—proceed directly to CTPA 1, 3
- D-dimer has limited value in this population and delays diagnosis 3
Hemodynamically Unstable Patients:
- Perform bedside echocardiography first to assess RV dysfunction
- If CTPA immediately available and patient stable enough for transport: obtain CTPA
- If patient too unstable: echocardiographic RV dysfunction confirms high-risk PE—initiate reperfusion without further imaging 4
Key Clinical Advantages of CTPA
Multidetector CTPA is the current standard of care for PE detection, with superior sensitivity compared to V/Q scanning 3. The modality offers several critical advantages:
- High diagnostic accuracy: Detects filling defects down to 2-3 mm in subsegmental arteries 3
- Prognostic information: Identifies RV dysfunction (RV/LV ratio >1.0), which predicts mortality and guides treatment intensity (thrombolysis vs. anticoagulation alone) 3
- Alternative diagnoses: Frequently reveals other pathology explaining symptoms (pneumonia, aortic dissection, malignancy) 3
- Low false-negative rate: Outcome studies show no adverse events in patients with negative CTPA who remain untreated 3
Contraindications and Special Considerations
Relative Contraindications:
- Renal insufficiency (iodinated contrast nephrotoxicity risk) 5
- Iodine allergy 5
- Severe contrast allergy requires premedication or alternative imaging (V/Q scan)
Pregnancy:
This remains controversial. The ATS/STR guidelines recommend V/Q scanning over CTPA primarily due to maternal breast radiation concerns, not fetal risk 3. However:
- Start with lower extremity duplex ultrasound if DVT symptoms present—positive DVT confirms VTE without radiation 3
- Fetal radiation from properly performed CTPA presents no measurable increased risk of malformation or developmental impairment 3
- Either modality is acceptable when imaging is required 3
Critical Pitfalls to Avoid
Overutilization Problem: Studies show CTPA is avoidable in 32%-48% of cases, primarily from failure to perform D-dimer testing first 3, 6, 7. This leads to:
- Unnecessary radiation exposure
- Increased costs
- Detection of clinically insignificant subsegmental PE (15% of positive CTPAs show isolated subsegmental PE of uncertain clinical significance) 3
- Overtreatment with anticoagulation and associated bleeding complications 3
The National Quality Forum measure: Failure to perform D-dimer testing accounts for nearly two-thirds of potentially avoidable CTPA studies 3.
D-dimer Limitations: The test has limited value in:
- Pregnant patients 3
- Postoperative patients 3
- Trauma patients 3
- Hospitalized patients 4
- High pretest probability patients 1, 3
Subsegmental PE Controversy: While CTPA detects very small distal clots, these remain of indeterminate clinical significance and some may not require treatment 3. This represents a double-edged sword of increased CT sensitivity.
When CTPA is Insufficient
Catheter pulmonary angiography is now rarely needed but remains indicated when: